| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP Finance CFO | SVP Finance &CFO
2 companies
Landry Robert E is an EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 123 sells.
Estimated insider holdings value: $15.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 512 | $631.27 | $323,211.73 | -0.3% | |
| Jun 11, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 988 | $612.08 | $604,731.02 | -0.4% | |
| Jun 9, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 4,271 | $608.01 | $2,596,792.32 | -1.7% | |
| Apr 20, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 4,241 | $564.77 | $2,395,200.61 | -0.7% | |
| Apr 15, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 853 | $518.49 | $442,275.87 | -0.6% | |
| Apr 13, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 828 | $509.79 | $422,107.79 | -0.4% | |
| Apr 7, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 696 | $497.52 | $346,270.62 | -1.4% | |
| Apr 3, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 788 | $494.49 | $389,659.42 | -0.2% | |
| Apr 2, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 1,848 | $488.90 | $903,482.61 | -0.3% | |
| Feb 26, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Finance CFO | Sale+OE | 414 | $452.49 | $187,330.47 | - |